Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
ENSG00000256176, labeled as "solute carrier family 25, member 13 pseudogene," refers to a non-functional, non-coding copy of the SLC25A13 gene. Pseudogenes are DNA sequences similar to functional genes but generally lack protein coding potential due to mutations or incomplete transcription. The functional SLC25A13 gene encodes for the protein citrin, a mitochondrial carrier involved in the malate-aspartate shuttle and amino acid transport, but the pseudogene itself has no known protein product, biological function, or disease association. Thus, it is not a therapeutic target nor associated with any interacting drugs or biomarker usage. This entry likely appears in genomic databases for reference or evolutionary studies, rather than for functional or therapeutic relevance. If information about the active, functional gene SLC25A13 (not the pseudogene) is needed, please specify. No drugs, disease roles, mechanisms, or biomarker information are associated with pseudogenes like ENSG00000256176.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Solute carrier family 25, member 13 pseudogene (SLC25A13P).